See more : fonfun corporation (2323.T) Income Statement Analysis – Financial Results
Complete financial analysis of West Pharmaceutical Services, Inc. (WST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of West Pharmaceutical Services, Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- Lonza Group AG (0QNO.L) Income Statement Analysis – Financial Results
- Knaus Tabbert AG (KTA.DE) Income Statement Analysis – Financial Results
- Churchill Capital Corp VI (CCVI) Income Statement Analysis – Financial Results
- Global Consumer Public Company Limited (GLOCON.BK) Income Statement Analysis – Financial Results
- Athena Global Technologies Limited (ATHENAGLO.BO) Income Statement Analysis – Financial Results
West Pharmaceutical Services, Inc. (WST)
About West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.95B | 2.89B | 2.83B | 2.15B | 1.84B | 1.72B | 1.60B | 1.51B | 1.40B | 1.42B | 1.37B | 1.27B | 1.19B | 1.10B | 1.06B | 1.05B | 1.02B | 913.30M | 699.70M | 541.60M | 490.70M | 419.70M | 396.90M | 430.10M | 469.10M | 449.70M | 452.50M | 458.80M | 412.90M | 365.10M | 348.70M | 338.20M | 329.60M | 323.20M | 308.70M | 288.20M | 253.30M | 235.60M | 190.10M |
| Cost of Revenue | 1.82B | 1.75B | 1.66B | 1.38B | 1.23B | 1.17B | 1.09B | 1.01B | 944.00M | 973.60M | 933.70M | 878.70M | 853.00M | 786.60M | 752.10M | 748.50M | 728.30M | 651.50M | 507.10M | 385.70M | 334.90M | 302.10M | 280.80M | 289.70M | 289.10M | 282.20M | 288.50M | 302.00M | 265.10M | 225.90M | 222.10M | 217.80M | 221.40M | 221.50M | 206.70M | 197.40M | 174.40M | 160.20M | 128.00M |
| Gross Profit | 1.13B | 1.14B | 1.18B | 767.80M | 605.70M | 545.40M | 512.60M | 501.10M | 455.80M | 447.80M | 434.70M | 387.70M | 339.30M | 318.10M | 303.60M | 302.60M | 291.80M | 261.80M | 192.60M | 155.90M | 155.80M | 117.60M | 116.10M | 140.40M | 180.00M | 167.50M | 164.00M | 156.80M | 147.80M | 139.20M | 126.60M | 120.40M | 108.20M | 101.70M | 102.00M | 90.80M | 78.90M | 75.40M | 62.10M |
| Gross Profit Ratio | 38.28% | 39.36% | 41.52% | 35.76% | 32.92% | 31.76% | 32.06% | 33.21% | 32.56% | 31.50% | 31.77% | 30.61% | 28.46% | 28.80% | 28.76% | 28.79% | 28.61% | 28.67% | 27.53% | 28.79% | 31.75% | 28.02% | 29.25% | 32.64% | 38.37% | 37.25% | 36.24% | 34.18% | 35.80% | 38.13% | 36.31% | 35.60% | 32.83% | 31.47% | 33.04% | 31.51% | 31.15% | 32.00% | 32.67% |
| Research & Development | 68.40M | 58.50M | 52.80M | 46.90M | 38.90M | 40.30M | 39.10M | 36.80M | 34.10M | 37.30M | 37.90M | 33.20M | 29.10M | 23.90M | 19.90M | 18.70M | 16.10M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 262.90M | 242.60M | 239.80M | 233.00M | 228.70M | 234.90M | 218.10M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 353.40M | 316.90M | 362.80M | 302.00M | 272.70M | 262.90M | 242.60M | 239.80M | 233.00M | 228.70M | 234.90M | 218.10M | 191.10M | 187.70M | 177.70M | 159.30M | 152.50M | 155.90M | 120.30M | 105.20M | 111.00M | 82.60M | 73.40M | 67.70M | 77.90M | 70.50M | 70.20M | 72.80M | 69.90M | 69.00M | 63.50M | 57.10M | 85.00M | 57.80M | 45.60M | 41.50M | 32.20M | 29.90M | 26.60M |
| Other Expenses | 31.50M | 26.80M | 7.90M | 12.00M | 2.40M | 4.80M | -2.00M | -27.70M | -60.10M | 200.00K | 500.00K | 5.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 454.00M | 402.20M | 423.50M | 360.90M | 311.60M | 303.20M | 281.70M | 276.60M | 267.10M | 266.00M | 272.80M | 251.30M | 221.70M | 213.30M | 197.60M | 191.90M | 168.60M | 160.80M | 121.70M | 106.70M | 94.30M | 81.00M | 71.90M | 104.70M | 113.60M | 102.80M | 102.10M | 103.50M | 99.50M | 92.10M | 85.50M | 80.70M | 109.50M | 80.50M | 65.90M | 60.40M | 49.00M | 44.60M | 38.60M |
| Cost & Expenses | 2.27B | 2.15B | 2.08B | 1.74B | 1.55B | 1.48B | 1.37B | 1.28B | 1.21B | 1.24B | 1.21B | 1.13B | 1.07B | 999.90M | 949.70M | 940.40M | 896.90M | 812.30M | 628.80M | 492.40M | 429.20M | 383.10M | 352.70M | 394.40M | 402.70M | 385.00M | 390.60M | 405.50M | 364.60M | 318.00M | 307.60M | 298.50M | 330.90M | 302.00M | 272.60M | 257.80M | 223.40M | 204.80M | 166.60M |
| Interest Income | 28.00M | 5.10M | 1.00M | 1.40M | 3.80M | 2.10M | 1.30M | 1.10M | 1.60M | 3.50M | 1.90M | 1.80M | 1.30M | 600.00K | 800.00K | 1.40M | 6.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 9.00M | 7.90M | 7.20M | 6.80M | 4.70M | 6.30M | 6.50M | 7.00M | 12.50M | 13.00M | 15.10M | 14.90M | 18.20M | 16.80M | 14.40M | 16.00M | 14.50M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 137.30M | 120.60M | 122.30M | 109.10M | 103.40M | 104.40M | 96.70M | 90.70M | 89.90M | 90.00M | 85.20M | 76.90M | 75.70M | 73.20M | 68.10M | 60.60M | 56.60M | 52.70M | 47.40M | 33.20M | 33.00M | 33.00M | 32.00M | 37.00M | 35.70M | 32.30M | 31.90M | 30.70M | 29.60M | 23.10M | 22.00M | 23.60M | 24.50M | 22.70M | 20.30M | 18.90M | 16.80M | 14.70M | 12.00M |
| EBITDA | 844.10M | 887.90M | 895.20M | 531.70M | 399.40M | 355.30M | 335.90M | 319.60M | 220.00M | 273.30M | 249.00M | 200.00M | 183.40M | 161.30M | 166.40M | 186.10M | 157.50M | 149.90M | 122.90M | 94.50M | 84.80M | 82.80M | 74.70M | 75.90M | 102.10M | 97.00M | 93.80M | 84.00M | 77.90M | 70.20M | 63.10M | 63.30M | 23.20M | 43.90M | 56.40M | 49.30M | 46.70M | 45.50M | 35.50M |
| EBITDA Ratio | 28.62% | 29.60% | 31.02% | 24.09% | 21.73% | 14.38% | 14.31% | 13.04% | 9.19% | 12.80% | 11.87% | 11.20% | 10.53% | 10.76% | 9.95% | 10.65% | 20.40% | 18.01% | 19.39% | 15.68% | 17.28% | 18.56% | 19.55% | 21.39% | 21.49% | 28.13% | 20.38% | 22.47% | 18.29% | 19.56% | 17.95% | 18.72% | 6.71% | 14.91% | 16.94% | 16.20% | 19.31% | 18.34% | 16.99% |
| Operating Income | 676.00M | 734.00M | 752.30M | 406.90M | 296.60M | 240.30M | 228.90M | 196.80M | 128.60M | 182.00M | 162.40M | 135.10M | 109.60M | 90.70M | 97.50M | 124.10M | 94.90M | 101.00M | 72.20M | 48.20M | 54.50M | 26.70M | 41.30M | 35.70M | 66.40M | 64.70M | 61.90M | 53.30M | 48.30M | 47.10M | 41.10M | 39.70M | -1.30M | 21.20M | 36.10M | 30.40M | 29.90M | 30.80M | 23.50M |
| Operating Income Ratio | 22.92% | 25.43% | 26.57% | 18.95% | 16.12% | 13.99% | 14.31% | 13.04% | 9.19% | 12.80% | 11.87% | 10.67% | 9.19% | 8.21% | 9.24% | 11.81% | 9.30% | 11.06% | 10.32% | 8.90% | 11.11% | 6.36% | 10.41% | 8.30% | 14.15% | 14.39% | 13.68% | 11.62% | 11.70% | 12.90% | 11.79% | 11.74% | -0.39% | 6.56% | 11.69% | 10.55% | 11.80% | 13.07% | 12.36% |
| Total Other Income/Expenses | 22.00M | -54.10M | -3.40M | -5.60M | -4.80M | 400.00K | -3.40M | -5.40M | -12.50M | -13.00M | -15.30M | -26.50M | -23.20M | -31.50M | -14.40M | -15.10M | -8.50M | -16.50M | -12.00M | -8.20M | -7.50M | -9.50M | -13.40M | -11.10M | -9.30M | -36.80M | -4.20M | -26.10M | -5.70M | -6.40M | -4.30M | -5.70M | -2.50M | -10.50M | -2.20M | -2.90M | -6.70M | -600.00K | 1.90M |
| Income Before Tax | 698.00M | 679.90M | 748.90M | 401.30M | 291.80M | 240.70M | 222.40M | 189.80M | 116.10M | 169.00M | 147.10M | 108.60M | 92.70M | 74.50M | 83.10M | 109.50M | 86.40M | 84.50M | 45.20M | 41.20M | 47.00M | 17.20M | 27.80M | 3.10M | 57.10M | 27.90M | 57.70M | 27.20M | 42.60M | 40.70M | 36.80M | 34.00M | -3.80M | 10.70M | 33.90M | 27.50M | 23.20M | 30.20M | 25.40M |
| Income Before Tax Ratio | 23.66% | 23.55% | 26.45% | 18.69% | 15.86% | 14.02% | 13.91% | 12.58% | 8.29% | 11.89% | 10.75% | 8.58% | 7.77% | 6.74% | 7.87% | 10.42% | 8.47% | 9.25% | 6.46% | 7.61% | 9.58% | 4.10% | 7.00% | 0.72% | 12.17% | 6.20% | 12.75% | 5.93% | 10.32% | 11.15% | 10.55% | 10.05% | -1.15% | 3.31% | 10.98% | 9.54% | 9.16% | 12.82% | 13.36% |
| Income Tax Expense | 122.30M | 114.70M | 107.20M | 72.50M | 59.00M | 41.40M | 80.90M | 54.40M | 26.30M | 47.20M | 40.20M | 32.70M | 23.50M | 13.60M | 13.50M | 23.70M | 17.20M | 24.60M | -400.00K | 11.10M | 16.70M | 4.10M | 8.60M | 1.50M | 18.40M | 21.20M | 13.30M | 10.80M | 13.90M | 13.40M | 14.30M | 14.30M | 4.70M | 6.40M | 13.20M | 10.10M | 9.50M | 13.20M | 10.40M |
| Net Income | 593.40M | 585.90M | 661.80M | 346.20M | 241.70M | 206.90M | 150.70M | 143.60M | 95.60M | 127.10M | 112.30M | 80.70M | 75.50M | 65.30M | 72.60M | 86.00M | 70.70M | 67.10M | 45.60M | 19.40M | 31.90M | 18.40M | -5.20M | 1.60M | 38.70M | 6.70M | 44.40M | 16.40M | 28.70M | 27.30M | 23.50M | 19.70M | -8.50M | 4.30M | 20.70M | 17.40M | 13.70M | 17.00M | 15.00M |
| Net Income Ratio | 20.12% | 20.30% | 23.37% | 16.13% | 13.14% | 12.05% | 9.42% | 9.52% | 6.83% | 8.94% | 8.21% | 6.37% | 6.33% | 5.91% | 6.88% | 8.18% | 6.93% | 7.35% | 6.52% | 3.58% | 6.50% | 4.38% | -1.31% | 0.37% | 8.25% | 1.49% | 9.81% | 3.57% | 6.95% | 7.48% | 6.74% | 5.82% | -2.58% | 1.33% | 6.71% | 6.04% | 5.41% | 7.22% | 7.89% |
| EPS | 7.99 | 7.88 | 8.90 | 4.68 | 3.27 | 2.80 | 2.04 | 1.96 | 1.33 | 1.79 | 1.61 | 1.19 | 1.12 | 0.98 | 1.11 | 1.33 | 1.08 | 1.05 | 0.75 | 0.57 | 0.75 | 0.33 | -0.09 | 0.03 | 0.65 | 0.10 | 0.67 | 0.25 | 0.43 | 0.43 | 0.37 | 0.32 | -0.14 | 0.07 | 0.32 | 0.27 | 0.21 | 0.27 | 0.24 |
| EPS Diluted | 7.88 | 7.73 | 8.67 | 4.57 | 3.21 | 2.74 | 1.99 | 1.91 | 1.30 | 1.75 | 1.57 | 1.15 | 1.08 | 0.95 | 1.06 | 1.25 | 1.02 | 1.00 | 0.71 | 0.56 | 0.75 | 0.33 | -0.09 | 0.03 | 0.64 | 0.10 | 0.67 | 0.25 | 0.43 | 0.43 | 0.37 | 0.31 | -0.14 | 0.07 | 0.32 | 0.27 | 0.21 | 0.27 | 0.24 |
| Weighted Avg Shares Out | 74.30M | 74.40M | 74.40M | 73.90M | 74.00M | 73.90M | 73.90M | 73.30M | 72.00M | 70.90M | 69.60M | 68.00M | 67.40M | 66.60M | 65.60M | 64.80M | 65.40M | 64.40M | 62.20M | 60.00M | 58.00M | 57.80M | 57.34M | 57.63M | 59.66M | 65.74M | 65.90M | 65.67M | 66.23M | 64.22M | 63.51M | 62.54M | 61.82M | 63.70M | 64.69M | 65.05M | 64.47M | 64.15M | 63.16M |
| Weighted Avg Shares Out (Dil) | 75.30M | 75.80M | 76.30M | 75.80M | 75.40M | 75.40M | 75.80M | 75.00M | 73.80M | 72.80M | 71.40M | 71.80M | 74.00M | 73.40M | 72.60M | 72.20M | 72.40M | 67.20M | 65.00M | 61.60M | 58.20M | 57.80M | 57.39M | 57.64M | 60.19M | 66.02M | 66.29M | 65.67M | 66.23M | 64.22M | 63.95M | 63.04M | 61.82M | 63.70M | 65.20M | 65.05M | 64.47M | 64.15M | 63.16M |
MMSI or WST: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Merit Medical (MMSI) or West Pharmaceutical Services (WST). But which of these two stocks presents investors with the better value opportunity right now?
Reasons to Hold West Pharmaceutical Stock in Your Portfolio Now
WST continues to gain momentum due to its strength in the Pharma market unit. However, decline across its Generics and Biologics business units is concerning.
Final Trade: West Pharma, Cameco, iShares Biotechnology ETF and Applied Digital Corp
The final trades of the day with the Fast Money traders.
17 Upcoming Dividend Increases
This week, 17 companies with an average dividend increase of 8.3% are highlighted, emphasizing consistent dividend growth and outperforming benchmarks. My investment strategy focuses on buying, holding, and adding companies with consistent dividend increases and superior performance compared to benchmarks....
West to Participate in Upcoming Investor Conferences
EXTON, Pa. , Oct. 29, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the following conferences: UBS Global Healthcare Conference in Rancho Pablos...
The Zacks Analyst Blog The Gorman-Rupp, Kontoor Brands, Kontoor Brands and Standex International
The Gorman-Rupp, Kontoor Brands, Kontoor Brands and Standex International are included in this Analyst Blog.
Buy These 4 Stocks With New Dividend Hikes Amid Market Volatility
Stocks like GRC, KTB, WST and SXI recently announced dividend hikes.
West Pharmaceutical Services, Inc. (WST) Q3 2024 Earnings Call Transcript
West Pharmaceutical Services, Inc. (NYSE:WST ) Q3 2024 Results Earnings Conference Call October 24, 2024 9:00 AM ET Company Participants John Sweeney - Vice President, Investor Relations Eric Green - Chairman, President and Chief Executive Officer Bernard Birkett - Senior...
West Pharmaceutical's Q3 Performance Shows Rising Demand For Syringes, Company Boosts Annual Forecast And Dividend
On Thursday, West Pharmaceutical Services, Inc. WST reported adjusted EPS of $1.85, down from $2.16 a year ago, beating the consensus of $1.50.
West Pharmaceutical Stock Gains on Q3 Earnings Beat & Raised Guidance
WST's third-quarter results reflect a recovery in the Proprietary Products segment following elevated customer destocking, hurting sales in the second quarter.
Source: https://incomestatements.info
Category: Stock Reports
What were West Pharmaceutical’s net sales in Q3 2024?
(NYSE: WST) today announced its financial results for the third-quarter 2024 and declared a fourth-quarter 2024 dividend. Net sales of $746.9 million declined 0.1%; organic net sales decline was 0.5%. Reported-diluted EPS of $1.85, compared to $2.14 in the same period last year.